Cargando…

Effectiveness of protocol-based pharmacotherapy management collaboration between hospital and community pharmacists to address capecitabine-related hand–foot syndrome in cancer patients: a retrospective study

BACKGROUND: Pharmaceutical care of capecitabine-related hand–foot syndrome (HFS) is extremely important to avoid the progression of the syndrome. Protocol-based pharmacotherapy management (PBPM) of HFS by community pharmacists has been introduced in our community, whereby the community pharmacist in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Nobuhiko, Shiraiwa, Hiroki, Haruna, Yasuhiro, Ichijima, Tomoki, Takeda, Tomoko, Hasegawa, Koji, Kusumoto, Masaaki, Yano, Yoshitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919314/ https://www.ncbi.nlm.nih.gov/pubmed/33641672 http://dx.doi.org/10.1186/s40780-021-00191-1

Ejemplares similares

Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine
por: Yoshimura, Yoshihiro, et al.
Publicado: (2022)

HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2009)

HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2008)

Role of pharmacist counseling in pharmacotherapy quality improvement
por: Sanii, Yalda, et al.
Publicado: (2016)

Optimizing pharmacotherapy in elderly patients: the role of pharmacists
por: Lee, Jeannie K, et al.
Publicado: (2015)

Impact of physician−pharmacist collaborative protocol-based pharmacotherapy management for HIV outpatients: a retrospective cohort study
por: Urano, Kimihiko, et al.
Publicado: (2020)

A novel study on clinical pharmacist and psychiatrist collaborative pharmacotherapy management services among elderly population with psychiatric illness
por: Samaksha, P. B., et al.
Publicado: (2022)

Pharmaceutical interventions by collaboration between staff pharmacists and clinical pharmacists and implementation of Joint Commission International Accreditation Standards on medication use may optimize pharmacotherapy in geriatric patients
por: Chen, Meng, et al.
Publicado: (2016)

Application of Novel Pharmacists’ Risk in Pharmacotherapy (PHARIPH) Scale for Identification of Factors Affecting the Safety of Hospital Pharmacotherapy—An Observational Pilot Study
por: Fedorowicz, Olga, et al.
Publicado: (2022)

Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?
por: Saif, Muhammad W, et al.
Publicado: (2016)

Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?
por: Caprez, Jennifer, et al.
Publicado: (2018)

Impact and feasibility of a pharmacist-delivered pharmacotherapy rotation on pediatric resident education
por: LaRochelle, Joseph M., et al.
Publicado: (2021)

Assessment of pharmacists' self-reported preparedness to provide pharmacotherapy services to individuals with psychiatric disorders
por: German, Alexander, et al.
Publicado: (2018)

Generalised Lichenoid Drug Eruption Accompanied by Hand-foot Syndrome Due to Capecitabine
por: Tamer, Funda, et al.
Publicado: (2018)

Hand-Foot Syndrome Presentation Post-Capecitabine Treatment in a Black Patient
por: Whorton, Allison E, et al.
Publicado: (2022)

Promoting Safer Use of High-Risk Pharmacotherapy: Impact of Pharmacist-Led Targeted Medication Reviews
por: Morrison, Clare, et al.
Publicado: (2015)

Insights Into Metformin XR Pharmacotherapy Knowledge Among Community Pharmacists: A Cross-Sectional Study
por: Jairoun, Ammar Abdulrahman, et al.
Publicado: (2023)

First Case of Foot Drop Associated with Capecitabine in a Patient with Thymidylate Synthase Polymorphism
por: Wilks, Andrew B, et al.
Publicado: (2017)

Hand-foot syndrome caused by capecitabine: incidence, risk factors and the role of dermatological evaluation
por: de Queiroz, Marina Vieira Rodrigues, et al.
Publicado: (2022)

Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)
por: Iimura, Yohei, et al.
Publicado: (2022)

Preparing Pharmacists for Collaborative/Integrated Health Settings
por: Ascione, Frank J.
Publicado: (2019)

Positive Impact of a Pilot Pharmacist-Run Diabetes Pharmacotherapy Clinic in Solid-Organ Transplant Recipients
por: Newland, David M., et al.
Publicado: (2018)

Positive Patient Postoperative Outcomes with Pharmacotherapy: A Narrative Review including Perioperative-Specialty Pharmacist Interviews
por: Parrish, Richard H., et al.
Publicado: (2022)

Hand-Foot Syndrome with Scleroderma-like Change Induced by the Oral Capecitabine: A Case Report
por: Lee, Sehe-Dong, et al.
Publicado: (2007)

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients
por: Kayikci, Emel Emine, et al.
Publicado: (2020)

Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer
por: Dong, Si-Qi, et al.
Publicado: (2021)

Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome – A literature review()
por: Nascimento, Anna Danielly Almeida do, et al.
Publicado: (2023)

Skin disorder management in oral anticancer drugs by collaboration of hospital pharmacists and community pharmacists
por: Urakawa, Ryuta, et al.
Publicado: (2020)

Overcoming Barriers in Nurse-Pharmacist Collaborations on Wards – Qualitative Expert Interviews with Nurses and Pharmacists
por: Wakob, Ines, et al.
Publicado: (2023)

General practitioners’ perceptions of the roles of community pharmacists and their willingness to collaborate with pharmacists in primary care
por: Chong, Joy Boon Ka, et al.
Publicado: (2023)

Pharmacists’ Perceptions of Physician–Pharmacist Collaboration—A 2022 Cross-Sectional Survey in Poland
por: Wrześniewska-Wal, Iwona, et al.
Publicado: (2023)

General practitioners-community pharmacists pharmacotherapy discussion groups: Analysis of their implementation through a series of case studies
por: Macé, Florent, et al.
Publicado: (2023)

Case Report: Various Abnormalities in Lipid and Glucose Metabolism Induced by Capecitabine
por: Anno, Takatoshi, et al.
Publicado: (2021)

An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?
por: Vasudevan, Biju
Publicado: (2010)

Compliance and Effective Management of the Hand-Foot Syndrome in Colon Cancer Patients Receiving Capecitabine as Adjuvant Chemotherapy
por: Son, Hyun-Sook, et al.
Publicado: (2009)

Treatment of capecitabine-induced hand-foot syndrome using a topical retinoid: A case report
por: INOKUCHI, MASAFUMI, et al.
Publicado: (2014)

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
por: Lin, Shaoyan, et al.
Publicado: (2019)

Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
por: Hiromoto, Shiori, et al.
Publicado: (2021)

Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report
por: Ahn, Ha Rim, et al.
Publicado: (2021)

Pharmacists as Interprofessional Collaborators and Leaders through Clinical Pathways
por: Ismail, Sherine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_imie2plrpkgfrfbbtkvrnecsnp